Boster Biological Technology, a life science reagent manufacturer based in Pleasanton, California, has broadened availability of its validated CD68 antibody marker, a rabbit monoclonal optimized for IHC performance in human FFPE specimens. Pleasanton, California, United States — Getting macrophage staining right in FFPE tissue has been a pain point for immunohistochemistry labs for years. Antigen […]
DURHAM, NC, USA and Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, today announced a partnership to help researchers generate high-confidence epigenomic insights faster. By combining EpiCypher’s CUTANA™ ChIC/CUT&RUN platform with Abcam’s expertise in antibody development and characterization, the collaboration […]
New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla. — TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing […]
Amsbio has expanded its diverse range of recombinant and monoclonal antibodies to include over 10,000 new validated monospecific products in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction. Every antibody in the new catalogue has been subject to rigorous validation technologies to confirm that they selectively recognize their intended targets across applications such as immunohistochemistry, western […]
Partnership expands access to next-generation protein quantitation technology across Japan’s biopharmaceutical and life sciences markets BILLERICA, Mass. — Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, today announced the appointment of S.T. Japan as its exclusive distribution partner for the TALOS™ protein quantitation system in Japan. S.T. Japan, a specialized provider […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling Technology (“CST”) to advance and validate next-generation protein sequencing and analysis of post-translational modifications (“PTM”) on the Proteus™ single-molecule protein sequencing platform. The partnership will focus on integrating CST’s […]
Acquisition Expands 10x Genomics’ Capabilities in Proteomics PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics, a division within Proteintech Group, a company specializing in developing high-plex proteomic solutions for single cell and spatial applications on 10x […]
BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22. Faessler brings extensive finance leadership experience and expertise in managing complex organizations in the life science tools industry, positioning him to play a […]
Cambridge, UK – Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced the appointment of Dr. Kaveh Kahen as President. Commenting on his appointment, Dr. Kahen said: “I’m honored to join Abcam as President. For over 25 years, Abcam has played a critical role in advancing life sciences research […]
MilliporeSigma appoints Clara Sattler de Sousa e Brito and Robert Machinek to strengthen leadership team. Clara Sattler de Sousa e Brito appointed Head of Discovery Solutions, bringing extensive international leadership experience across healthcare, medtech and the chemical industry Robert Machinek appointed Head of Strategy & Business Development, bringing deep expertise in life science strategy, M&A […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
